[go: up one dir, main page]

AU3891299A - Combination therapy for treatment of depression - Google Patents

Combination therapy for treatment of depression

Info

Publication number
AU3891299A
AU3891299A AU38912/99A AU3891299A AU3891299A AU 3891299 A AU3891299 A AU 3891299A AU 38912/99 A AU38912/99 A AU 38912/99A AU 3891299 A AU3891299 A AU 3891299A AU 3891299 A AU3891299 A AU 3891299A
Authority
AU
Australia
Prior art keywords
depression
treatment
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38912/99A
Inventor
David . Michelson
Gary Dennis Tollefson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3891299A publication Critical patent/AU3891299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU38912/99A 1998-05-21 1999-05-10 Combination therapy for treatment of depression Abandoned AU3891299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8626898P 1998-05-21 1998-05-21
US60086268 1998-05-21
PCT/US1999/010092 WO1999059593A1 (en) 1998-05-21 1999-05-10 Combination therapy for treatment of depression

Publications (1)

Publication Number Publication Date
AU3891299A true AU3891299A (en) 1999-12-06

Family

ID=22197424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38912/99A Abandoned AU3891299A (en) 1998-05-21 1999-05-10 Combination therapy for treatment of depression

Country Status (5)

Country Link
EP (1) EP1077704A4 (en)
JP (1) JP2002515435A (en)
AU (1) AU3891299A (en)
CA (1) CA2332253A1 (en)
WO (1) WO1999059593A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
EP1133299A1 (en) * 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
GB2362826A (en) * 2000-06-02 2001-12-05 Lilly Co Eli A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US6635675B2 (en) * 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
AU2003252318A1 (en) * 2002-08-09 2004-02-25 Mitsubishi Pharma Corporation Regulator for mental disease risk fragility
US7704527B2 (en) 2002-10-25 2010-04-27 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
WO2004039361A1 (en) 2002-10-25 2004-05-13 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
AR042806A1 (en) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd COMBINATION OF CARBOSTIRILE DERIVATIVES AND INHIBITORS OF SEROTONINE REABSORTION FOR THE TREATMENT OF ANIMO DISORDERS
EP1723957A3 (en) 2002-12-27 2013-01-23 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
EP1592453A1 (en) * 2003-01-28 2005-11-09 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
FR2851163B1 (en) * 2003-02-14 2007-04-27 USE OF DEXTROGYAN ENANTIOMER OF MILNACIPRAN FOR THE PREPARATION OF A MEDICINAL PRODUCT
EP1795196A3 (en) * 2003-04-04 2008-02-06 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James Combination therapy for dementia,depression and apathy
PL1912650T3 (en) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Use of flibanserin in the treatment of obesity
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
JP2009541443A (en) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Flibanserin for the treatment of urinary incontinence and related diseases
CL2007002214A1 (en) 2006-08-14 2008-03-07 Boehringer Ingelheim Int PHARMACEUTICAL COMPOSITION IN THE FORM OF COMPRESSED, WHERE AT LEAST THE LENGTH OF THE COMPRESSED IN THE PREVIOUS STATE OF THE APPLICATION IS AT LEAST 7/12 OF THE PILOR DIAMETER OF THE PATIENT AND AFTER INGERING IT IN THE FOOD STATE, THE LENGTH OF THE COMP
KR20090045945A (en) 2006-08-25 2009-05-08 베링거 인겔하임 인터내셔날 게엠베하 Controlled Release System and Manufacturing Method Thereof
CL2008002693A1 (en) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Use of flibanserin for the treatment of selected vasomotor symptoms of hot flashes, night sweats, mood swings, and irritability
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3788057T2 (en) * 1986-12-17 1994-03-03 Glaxo Group Ltd Use of heterocyclic compounds for the treatment of depression.
WO1992000103A1 (en) * 1990-06-28 1992-01-09 Beecham Group Plc Pharmaceutical preparations
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia

Also Published As

Publication number Publication date
WO1999059593A1 (en) 1999-11-25
JP2002515435A (en) 2002-05-28
EP1077704A1 (en) 2001-02-28
EP1077704A4 (en) 2002-01-30
CA2332253A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AU3891299A (en) Combination therapy for treatment of depression
AU9028798A (en) Method of improving drug treatment
AU4411297A (en) Combination therapy for treatment of psychoses
AU4067697A (en) Therapeutic compositions for treatment of cancer
IL139592A0 (en) Combination therapy for treatment of refractory depression
AU3784999A (en) Methods for treatment of pain
AU3596199A (en) Treatment of celiac disease
AU3988099A (en) Combination therapy for treating hypercholesterolemia
AU3896900A (en) Treatment of pain
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
AU3760900A (en) Treatment of menstrual function
IL135994A0 (en) Combination therapy for the treatment of aids
AU1940800A (en) Combination therapy for the treatment of sepsis
AU2566201A (en) Compounds and methods for the treatment of pain
AU1405001A (en) Treatment of diseases
AU5778399A (en) Gene therapy for treatment of cancer
AU7545998A (en) Treatment of osteoporosis
AU2420201A (en) Compounds and methods for the treatment of pain
AU4219799A (en) Combination therapy for treatment of fiv infection
AUPP229598A0 (en) Treatment of sunburn
AU6112299A (en) Treatment of effluents
AU4406899A (en) Progesterone treatment of cancer
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
HUP0103568A3 (en) Treatment of depression
AU4014800A (en) Treatment of gallstones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase